Form 8-K - Current report:
SEC Accession No. 0001564590-19-035426
Filing Date
2019-09-25
Accepted
2019-09-25 16:20:31
Documents
14
Period of Report
2019-09-25
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mygn-8k_20190925.htm   iXBRL 8-K 38112
2 EX-99.1 mygn-ex991_55.htm EX-99.1 16904
3 GRAPHIC gld5wnksfvyq000001.jpg GRAPHIC 4230
  Complete submission text file 0001564590-19-035426.txt   193611

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA mygn-20190925.xsd EX-101.SCH 5960
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE mygn-20190925_lab.xml EX-101.LAB 18732
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mygn-20190925_pre.xml EX-101.PRE 11167
8 EXTRACTED XBRL INSTANCE DOCUMENT mygn-8k_20190925_htm.xml XML 3412
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108 801-584-3600
MYRIAD GENETICS INC (Filer) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-26642 | Film No.: 191114441
SIC: 2835 In Vitro & In Vivo Diagnostic Substances